Can ADC differentiate cellular from acellular mucin in mucinous adenocarcinoma tumor beds after treatment of rectal cancer? A multicenter study
Maria El Homsi(Memorial Sloan Kettering Cancer Center), Marc J. Gollub(Memorial Sloan Kettering Cancer Center), Stéphanie Nougaret(Inserm), Yousef Mazaheri(Memorial Sloan Kettering Cancer Center), Stephanie Lobaugh(Memorial Sloan Kettering Cancer Center), Courtney Moreno(Emory University), S. H. Lee(University of California, Irvine Medical Center), Marina J Corines(Memorial Sloan Kettering Cancer Center), Shannon P. Sheedy(Mayo Clinic), Randy D. Ernst(The University of Texas MD Anderson Cancer Center), Marinela Capanu(Memorial Sloan Kettering Cancer Center), Natally Horvat(Mayo Clinic in Arizona), Onur Yildirim(Memorial Sloan Kettering Cancer Center), Jonathan Kuten(Memorial Sloan Kettering Cancer Center), Akshay Baheti(Homi Bhabha National Institute), Elena Korngold(Oregon Health & Science University)
Cited by 0
Related Papers
Preoperative Treatment of Locally Advanced Rectal Cancer
|New England Journal of Medicine|2023|440
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper
|Nature Reviews Clinical Oncology|2020|365
O-RADS MRI Risk Stratification System: Guide for Assessing Adnexal Lesions from the ACR O-RADS Committee
|Radiology|2022|196
Society of Abdominal Radiology (SAR) and European Society of Urogenital Radiology (ESUR) joint consensus statement for MR imaging of placenta accreta spectrum disorders
|European Radiology|2020|172
Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048)
|Journal of Clinical Oncology|2023|136